198 related articles for article (PubMed ID: 10868309)
1. Absence of pharmacokinetic drug interaction of levetiracetam with phenytoin in patients with epilepsy determined by new technique.
Browne TR; Szabo GK; Leppik IE; Josephs E; Paz J; Baltes E; Jensen CM
J Clin Pharmacol; 2000 Jun; 40(6):590-5. PubMed ID: 10868309
[TBL] [Abstract][Full Text] [Related]
2. Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials.
Gidal BE; Baltès E; Otoul C; Perucca E
Epilepsy Res; 2005; 64(1-2):1-11. PubMed ID: 15823510
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.
Milligan TA; Hurwitz S; Bromfield EB
Neurology; 2008 Aug; 71(9):665-9. PubMed ID: 18725591
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy.
Lancelin F; Franchon E; Kraoul L; Garciau I; Brovedani S; Tabaouti K; Landré E; Chassoux F; Paubel P; Piketty ML
Ther Drug Monit; 2007 Oct; 29(5):576-83. PubMed ID: 17898647
[TBL] [Abstract][Full Text] [Related]
5. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
[TBL] [Abstract][Full Text] [Related]
6. Levetiracetam monotherapy in children with epilepsy.
Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of levetiracetam: a review of three pivotal clinical trials.
Privitera M
Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
[TBL] [Abstract][Full Text] [Related]
8. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
[TBL] [Abstract][Full Text] [Related]
9. Tolerability and efficacy of oral loading of levetiracetam.
Koubeissi MZ; Amina S; Pita I; Bergey GK; Werz MA
Neurology; 2008 May; 70(22 Pt 2):2166-70. PubMed ID: 18505995
[TBL] [Abstract][Full Text] [Related]
10. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
[TBL] [Abstract][Full Text] [Related]
11. Lack of a clinically significant effect of zonisamide on phenytoin steady-state pharmacokinetics in patients with epilepsy.
Levy RH; Ragueneau-Majlessi I; Garnett WR; Schmerler M; Rosenfeld W; Shah J; Pan WJ
J Clin Pharmacol; 2004 Nov; 44(11):1230-4. PubMed ID: 15496640
[TBL] [Abstract][Full Text] [Related]
12. Preliminary efficacy of levetiracetam in monotherapy.
Ben-Menachem E
Epileptic Disord; 2003 May; 5 Suppl 1():S51-5. PubMed ID: 12915342
[TBL] [Abstract][Full Text] [Related]
13. Intravenous levetiracetam in children with epilepsy.
Goraya JS; Khurana DS; Valencia I; Melvin JJ; Cruz M; Legido A; Kothare SV
Pediatr Neurol; 2008 Mar; 38(3):177-80. PubMed ID: 18279751
[TBL] [Abstract][Full Text] [Related]
14. Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus.
Uges JW; van Huizen MD; Engelsman J; Wilms EB; Touw DJ; Peeters E; Vecht CJ
Epilepsia; 2009 Mar; 50(3):415-21. PubMed ID: 19054418
[TBL] [Abstract][Full Text] [Related]
15. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
[TBL] [Abstract][Full Text] [Related]
16. Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study.
Wheless JW; Clarke D; Hovinga CA; Ellis M; Durmeier M; McGregor A; Perkins F
J Child Neurol; 2009 Aug; 24(8):946-51. PubMed ID: 19264738
[TBL] [Abstract][Full Text] [Related]
17. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
Kaminski RM; Matagne A; Patsalos PN; Klitgaard H
Epilepsia; 2009 Mar; 50(3):387-97. PubMed ID: 18627416
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of levetiracetam in infants and young children with epilepsy.
Glauser TA; Mitchell WG; Weinstock A; Bebin M; Chen D; Coupez R; Stockis A; Lu ZS
Epilepsia; 2007 Jun; 48(6):1117-22. PubMed ID: 17442002
[TBL] [Abstract][Full Text] [Related]
19. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
[TBL] [Abstract][Full Text] [Related]
20. Modeling and simulation of intravenous levetiracetam pharmacokinetic profiles in children to evaluate dose adaptation rules.
Snoeck E; Jacqmin P; Sargentini-Maier ML; Stockis A
Epilepsy Res; 2007 Sep; 76(2-3):140-7. PubMed ID: 17851036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]